To place the observed HMGN1 downregulation in a biologically meaningful context, we examined the role of this gene in breast-cancer dormancy — an epigenetic-driven, non-replicative state, from which cancer cells “awaken”, causing cancer relapse and resistance to therapy. Here, HMGN1 is linked to breast carcinoma.